Cargando…
PAX1 hypomethylation as a prognostic biomarker for radioresistance of cervical cancer
BACKGROUND: PAX1 gene methylation plays an important role in the development of cervical cancer. However, its prognostic value after radiotherapy for locally advanced cervical cancer is unknown, so this study aimed to investigate the value of PAX1 gene methylation for predicting the sensitivity of r...
Autores principales: | Li, Xuanxuan, Liu, Huan, Zhou, Xue, Zhou, Yangying, Zhang, Yu, Liou, Yu-Ligh, Zeng, Manting, Zhu, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398938/ https://www.ncbi.nlm.nih.gov/pubmed/37533109 http://dx.doi.org/10.1186/s13148-023-01538-1 |
Ejemplares similares
-
Methylation of PAX1 gene promoter in the prediction of concurrent chemo-radiotherapy efficacy in cervical cancer
por: Li, Xuanxuan, et al.
Publicado: (2021) -
Real-time colorimetric detection of DNA methylation of the PAX1 gene in cervical scrapings for cervical cancer screening with thiol-labeled PCR primers and gold nanoparticles
por: Huang, Jin, et al.
Publicado: (2016) -
Identification of a Novel Transcription Factor Prognostic Index for Breast Cancer
por: Liu, Junhao, et al.
Publicado: (2021) -
DNA Methylation Status of PAX1 and ZNF582 in Esophageal Squamous Cell Carcinoma
por: Huang, Jin, et al.
Publicado: (2017) -
AP4M1 as a prognostic biomarker associated with cell proliferation, migration and immune regulation in hepatocellular carcinoma
por: Peng, Yuanhao, et al.
Publicado: (2023)